Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

References

• World Health Organization. Global measles and rubella strategic plan: 2012–2020. [Internet]. 2012 [accessed 2017 Jan 23]. http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396%5Feng.pdf
   Google Scholar
• Orenstein WA, Hinman A, Nkowane B, Olive JM, Reingold A. Measles and Rubella Global Strategic Plan 2012–2020 midterm review. Vaccine. 2018 Jan;36:A1–34. doi:10.1016/j.vaccine.2017.09.026.
   PubMed Web of Science ®Google Scholar
• Endean C (ed.). Gavi Progress Report 2015. The Global Alliance for Vaccines and Immunization; 2015. Report No.: 2016.
   Google Scholar
• Motaze NV, Suchard M, Cohen C, Baker L, Blumberg L (eds), Vaccine information for parents & caregivers [Internet]. Johannesburg: Ideas Wise and Wonderful for National Institute for Communicable Diseases; 2016 [accessed 2018 Feb 15]. http://www.nicd.ac.za/assets/files/NICD_Vaccine_Booklet_D132_FINAL.pdf
   Google Scholar
• Organization WH, others. Immunological basis for immunization: rubella. 2008 [accessed 2017 Jan 22]. http://apps.who.int/iris/handle/10665/43922
   Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;29(86):301–16.
   Google Scholar
• Luce R, Masresha B, Katsande R, Fall A, Shibeshi M. The impact of recent rubella vaccine introduction in 5 countries in the African region. J Immunol Sci. 2018 Sep 1;2(SI1):108–12. doi:10.29245/2578-3009/2018/si.1116.
   Google Scholar
• World Health Organization, Expanded Programme on Immunization, World Health Organization, Department of Immunization V and B. Introducing rubella vaccine into national immunization programmes: a step-by-step guide [Internet]. 2015 [accessed 2017 May 18]. http://apps.who.int/iris/bitstream/10665/184174/1/9789241549370_eng.pdf
   Google Scholar
• Mirambo MM, Majigo M, Aboud S, Groß U, Mshana SE. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res Notes. 2015 Dec;8(1):716. doi:10.1186/s13104-015-1711-x.
   PubMedGoogle Scholar
• Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, et al. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: the added value of nesting a serological survey within a post-campaign coverage evaluation survey. Vaccine. 2019 Apr;37(17):2387–93. doi:10.1016/j.vaccine.2019.02.037.
   PubMed Web of Science ®Google Scholar
• Barreto J, Sacramento I, Robertson SE, Langa J, de Gourville E, Wolfson L, Schoub BD. Antenatal rubella serosurvey in Maputo, Mozambique: antenatal rubella serosurvey in maputo, mozambique. Trop Med Int Health. 2006 Apr;11(4):559–64. doi:10.1111/tmi.2006.11.issue-4.
   PubMed Web of Science ®Google Scholar
• Poethko-Müller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in german children and adolescents and predictors for seronegativity. Borrow R, editor. PLoS ONE. 2012 Aug 6;7(8):e42867. doi:10.1371/journal.pone.0042867.
   PubMed Web of Science ®Google Scholar
• Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ. Seroprevalence of measles, mumps, rubella and varicella antibodies in the united states population, 2009–2010. Open Forum Infect Dis. 2015 Feb 19;2(1):ofv006–ofv006. doi:10.1093/ofid/ofv006.
   PubMed Web of Science ®Google Scholar
• Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Lankarani KB. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS One. 2013;8(1):e55043. doi:10.1371/journal.pone.0055043.
   PubMed Web of Science ®Google Scholar
• Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, Yoshida L-M, Brown DWJ, Jackson C, Strebel PM, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996–2010: a systematic review. PLoS One. 2016;11(3):e0149160. doi:10.1371/journal.pone.0149160.
   PubMed Web of Science ®Google Scholar
• Grenfell BT, Anderson RM. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond). 1985;95(2):419–36. doi:10.1017/S0022172400062859.
   PubMedGoogle Scholar
• Kinoshita R, Nishiura H. Assessing herd immunity against rubella in Japan: a retrospective seroepidemiological analysis of age-dependent transmission dynamics. BMJ Open. 2016;6(1):e009928. doi:10.1136/bmjopen-2015-009928.
   PubMed Web of Science ®Google Scholar
• Ghafourian M, Shakunia A, SM A, Kooti W, Shakerinejad G, Serajian A, Chinipardaz Z. Seroepidemiology of rubella in women under 25 years old attending medical centers in Ahvaz, Iran in 2013. Jundishapur J Microbiol [Internet]. 2015 Dec 26;8(12). [accessed 2016 Apr 11]. http://www.jjmicrobiol.com/?page=article&article_id=27896
   Web of Science ®Google Scholar
• Schoub BD, Harris BN, McAnerney J, Blumberg L. Rubella in South Africa: an impending Greek tragedy? SAMJ South Afr Med J. 2009;99:515–19.
   Web of Science ®Google Scholar
• Corcoran C, Hardie D. Seroprevalence of rubella antibodies among antenatal patients in the Western Cape. S Afr Med J. 2005;95:688–90.
   PubMed Web of Science ®Google Scholar
• Council for Medical Schemes Annual Report 2018/19 [Internet]. Council for Medical Schemes; 2019 [accessed 2019 Dec 10]. http://www.medicalschemes.com/files/Annual%20Reports/CMSAR2018_19.pdf
   Google Scholar
• Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, Kamupota M, Gerede R, Munyoro M, Mangwanya D, et al. Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. 2015 Dec;15(1):294. doi:10.1186/s12889-015-1642-4.
   PubMedGoogle Scholar
• Mirambo MM, Aboud S, Mushi MF, Seugendo M, Majigo M, Groß U, Mshana SE. Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania. Ital J Pediatr. 2016 Dec;42(1):54. doi:10.1186/s13052-016-0264-5.
   PubMedGoogle Scholar
• Nimpa Mengouo M, Ndze VN, Baonga F, Kobela M, Wiysonge CS. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014. BMJ Open. 2017 Apr;7(4):e012959. doi:10.1136/bmjopen-2016-012959.
   PubMed Web of Science ®Google Scholar
• Njeru I, Onyango D, Ajack Y, Kiptoo E. Rubella outbreak in a Rural Kenyan District, 2014: documenting the need for routine rubella immunization in Kenya. BMC Infect Dis [Internet]. 2015 Dec;15(1). [accessed 2016 Mar 18]. http://www.biomedcentral.com/1471-2334/15/245
   PubMedGoogle Scholar
• Hong H, Makhathini L, Mashele M, Malfeld S, Motsamai T, Sikhosana L, Manamela J, Ntshoe G, Motaze NV, Smit S, et al. Annual measles and rubella surveillance review, South Africa. Commun Dis Surveill Bull. 2017;16(2):14.
   Google Scholar
• Tamirat B, Hussen S, Shimelis T. Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study. BMJ Open. 2017 Oct;7(10):e016824. doi:10.1136/bmjopen-2017-016824.
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74. doi:10.1371/journal.pmed.0050074.
   PubMed Web of Science ®Google Scholar
• Global vaccine action plan. Vaccine. World Health Organization. 2013 Apr;31:B5–31. doi:10.1016/j.vaccine.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Statistics South Africa. Mid-year population estimates 2016 [Internet]. 2017 [accessed 2017 Mar 14]. https://www.statssa.gov.za/publications/P0302/P03022016.pdf
   Google Scholar
• Blaizot S, Herzog SA, Abrams S, Theeten H, Litzroth A, Hens N. Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling. BMC Med Res Methodol. 2019 Dec;19(1):51. doi:10.1186/s12874-019-0692-1.
   PubMedGoogle Scholar